Abstracts

ACCEPTABILITY OF PrEP AMONG A LARGE COHORT OF YOUNG TRANSGENDER WOMEN IN 2 US CITIES

Truvada as Pre-exposure prophylaxis (PrEP) is an efficacious biomedical prevention modality for individuals at increased risk of becoming infected with HIV, including young transgender women (YTW). However, no published studies to our knowledge have examined PrEP acceptability and its associated factors among this group. The current study examined the prevalence of PrEP acceptability and related…